Skip to content

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Amgen logo
AmgenAMGN
4.1%+0.6pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-3.6%-1.8pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-13.6%-5.7pp
Erasca, Inc. logo
Erasca, Inc.ERAS
-5.5%-2.6pp
Immunome logo
ImmunomeIMNM
-9.1%-3.9pp

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Calculated from IDEAYA Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s earnings yield?
IDEAYA Biosciences, Inc. (IDYA) reported earnings yield of -4.8% in Q1 2026.
How has IDEAYA Biosciences, Inc.'s earnings yield changed year-over-year?
IDEAYA Biosciences, Inc.'s earnings yield increased by 77.6% year-over-year, from -21.4% to -4.8%.
What is the long-term trend for IDEAYA Biosciences, Inc.'s earnings yield?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s earnings yield has grown at a -10.1% compound annual growth rate (CAGR), from -6.4% to -3.8%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.